Resurrect Bio Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Resurrect Bio Ltd - overview
Established
2021
Location
London, -, UK
Primary Industry
Agribusiness
About
Based in London, UK, and founded in 2021 by its CEO, Dr. Cian Duggan, and co-founder, Dr. Tolga Bozkurt, Resurrect Bio Ltd. operates as a plant biotech company that works to improve crop species' immune systems to prevent the spread of illnesses induced by climate change.
In February 2026, Resurrect Bio Ltd raised USD 8. 1 million in series A funding led by Corteva Catalyst, with participation from Pymwymic, Calculus Capital, Future Planet Capital, SynBioVen, and AgFunder. Resurrect Bio Ltd. creates a crop immune system that allows soy crops to protect themselves against diseases such as soybean cyst nematode, which causes significant production loss.
It also permits the reviving of important immune resistance genes (R-genes) that have been lost during generations of breeding by utilizing its technology of immune receptor networks in plants and pathogen-effector biology.
Current Investors
AgFunder, SynBioVen, Shake Climate Change
Primary Industry
Agribusiness
Sub Industries
Farm Support Services
Website
www.resurrect.bio
Verticals
Agtech, Artificial Intelligence
Company Stage
Series A
Total Amount Raised
Subscriber access only
Resurrect Bio Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.